Three opioid pharmacotherapy
agents (naltrexone, buprenorphine, and methadone) show moderate benefit for reducing relapse and increasing treatment retention.
In this study, a total of 228 patients were randomized to either four weeks of dTMS or standard TMS in conjunction with standard pharmacotherapy
, or to a control group treated with pharmacotherapy
Terplan: The standard of care for treatment of opioid use disorder in pregnancy is pharmacotherapy
with either methadone or buprenorphine (TABLE) plus behavioral counseling--ideally, co-located with prenatal care.
After identifying patients with obesity, the writing group said, a "multimodal and graduated approach to treatment" for these patients is generally warranted, with a focus on dietary and lifestyle changes, and use of pharmacotherapy
and bariatric surgery if indicated.
Similar to pharmacotherapy
, little is known about the effectiveness of CBT-I for pregnant women.
(2) Evidence-based psychotherapies for addiction, including motivational interviewing, cognitive-behavioral therapy, relapse prevention, contingency management, skills training, and/or case management, are a necessity, (3,5) and must be balanced with rational and appropriate pharmacotherapy
targeting both the SUD as well as the other disorder (Table 2, (2,3,5-9) page 27).
CBT is comparable to pharmacotherapy
for improving measures of sleep (SOR: A, comparative meta-analysis).
In clinical practice, patients with uncontrolled depression might not be offered electroconvulsive therapy for months or years, despite evidence from multiple studies that it is significantly more effective than pharmacotherapy
in that setting, Mr.
NEW ORLEANS -- A reasonable stepwise approach to pharmacotherapy
for agitation in outpatient dementia begins with a judiciously chosen SSRI as first-line therapy with the second-line consisting of augmentation with a benzodiazepine, M.
However, a greater severity of symptoms necessarily implies a greater dose of pharmacological treatment, a worse prognosis and an increased risk of adverse effects secondary to pharmacotherapy
and lack of control of the disease.
Although previous studies indicated that increased OGTT glucose concentrations were related to adverse gestational and fetal outcome [8, 9], their specific performance for the prediction of pharmacotherapy
in patients meeting the IADPSG criteria is less well investigated.